These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16928137)

  • 1. A model study of interactions between TcAChE peripheral site segment Tyr70Val71 and loop 1 of Fasciculin 2.
    Wang J; Gu J; Leszczynski J
    J Biomol Struct Dyn; 2006 Oct; 24(2):139-48. PubMed ID: 16928137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen-bonding interactions in the binding of loop 1 of fasciculin 2 to Torpedo californica acetylcholinesterase: a density functional theory study.
    Wang J; Gu J; Leszczynski J
    J Phys Chem B; 2005 Jul; 109(28):13761-9. PubMed ID: 16852724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
    Bui JM; Radic Z; Taylor P; McCammon JA
    Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
    Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
    Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
    J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
    van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
    Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
    Rosenberry TL; Rabl CR; Neumann E
    Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
    Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
    Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex.
    Radić Z; Taylor P
    J Biol Chem; 2001 Feb; 276(7):4622-33. PubMed ID: 11036076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2.
    Bui JM; Tai K; McCammon JA
    J Am Chem Soc; 2004 Jun; 126(23):7198-205. PubMed ID: 15186156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein complex formation by acetylcholinesterase and the neurotoxin fasciculin-2 appears to involve an induced-fit mechanism.
    Bui JM; McCammon JA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15451-6. PubMed ID: 17021015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
    Radić Z; Kirchhoff PD; Quinn DM; McCammon JA; Taylor P
    J Biol Chem; 1997 Sep; 272(37):23265-77. PubMed ID: 9287336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptides mimicking the binding site of human acetylcholinesterase for its inhibitor fasciculin 2.
    Kafurke U; Erijman A; Aizner Y; Shifman JM; Eichler J
    J Pept Sci; 2015 Sep; 21(9):723-30. PubMed ID: 26200472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
    Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
    J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G; Swart C; Moore SW
    Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylcholinesterase from snake venoms].
    Cousin X; Bon C
    C R Seances Soc Biol Fil; 1997; 191(3):381-400. PubMed ID: 9295965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations.
    Xu Y; Shen J; Luo X; Silman I; Sussman JL; Chen K; Jiang H
    J Am Chem Soc; 2003 Sep; 125(37):11340-9. PubMed ID: 16220957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
    Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
    J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.